The Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a critical vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $999,999,999 single-award IDC, which runs through November 2026, encompasses the delivery of specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains, including cardiovascular health, diabetes management, mental health treatments, pain management, infectious disease prevention, and general medical care. This IDC serves as the primary mechanism for the DLA to efficiently procure essential healthcare commodities for military and veteran healthcare needs, leveraging Amerisourcebergen's extensive supply chain and distribution capabilities.
In addition to the DLA IDC, Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, which covers similar medical products and prescription drugs. These IDCs demonstrate the company's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale, without any set-aside requirements, reflecting its strong position in the pharmaceutical distribution market.
Generated 7/2/25, 10:36 PM